Yahoo! JAPAN

2024/4/8 -Kelun-Biotech has established a complete innovative drug clinical research and operation platform under the protection of its electronic management system. The ...

2024/4/10 -Merck and Kelun-Biotech's antibody-drug conjugate achieved a 22% objective response rate and 80.5% disease control rate in heavily pretreated patients with ...

2024/3/18 -In May 2022 Merck paid Kelun $47m for undisclosed ADC projects later revealed to include saci-tirumo. The tally of disclosed phase 3 trials now comprises four ...

2024/4/8 -Kelun-Biotech (6990.HK) is a holding subsidiary of Kelun Pharmaceutical (002422.SZ), which focuses on the R&D, manufacturing, commercialization and global ...

2024/2/29 -Gene-Modified Cell Therapy to Target CD33 for Relapsed and Refractory Acute Myeloid Leukemiais under clinical development by Sichuan Kelun Bio-Tech ...

2024/4/5 -Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, the “Company”) will present the results of two clinical studies of anti-TROP2 ADC sacituzumab ...

2024/4/10 -Merck and Kelun-Biotech's antibody-drug conjugate achieved a 22% objective response rate and 80.5% disease control rate in heavily pretreated patients with…

2024/3/13 -Sichuan Kelun-Biotech Biopharmaceutical Co. surged 29% in Hong Kong and another drugmaker InnoCare Pharma Ltd. rose as much as 13% in mainland trading.

3日前 -Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. research and ratings by Barron's. View 6990 revenue estimates and earnings estimates, as well as in-depth ...

4日前 -Sichuan Kelun Pharmaceutical Co., Ltd. specializes in developing, manufacturing and marketing pharmaceuticals. Net sales break down by activity as follows: